Accepted: 5 August 2020
First Online: 15 September 2020
: J.S.M. consults for and holds stock in Fate Therapeutics and GT Biopharma. These competing interests have been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policy. J.A.M. declares no competing interests.